These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1279288)

  • 41. Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: a review of hypertension and BPH studies.
    Lund-Johansen P; Kirby RS
    Blood Press Suppl; 2003 May; 1():5-13. PubMed ID: 12800982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical ease of using doxazosin in BPH patients with and without hypertension.
    Steers WD; Kirby RS
    Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Fogari E; Salvadeo SA; Ferrari I; Gravina A; Fassi R; Fogari R
    Clin Drug Investig; 2006; 26(9):529-39. PubMed ID: 17163286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    Ahaneku JE
    Kobe J Med Sci; 1996 Feb; 42(1):19-29. PubMed ID: 8984227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients.
    Zou D; Grote L; Eder DN; Radlinski J; Hedner J
    Sleep Med; 2010 Mar; 11(3):325-8. PubMed ID: 20171140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.
    Grimm RH; Flack JM; Schoenberger JA; Gonzalez NM; Liebson PR
    Am J Hypertens; 1996 May; 9(5):445-54. PubMed ID: 8735175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Open trial of doxazosin in hypertensive Africans: dose finding, efficacy and safety studies.
    Sowunmi A; Salako LA; Walker O
    Afr J Med Med Sci; 1996 Mar; 25(1):53-9. PubMed ID: 9110055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus.
    Svarstad E; Gerdts E; Omvik P; Ofstad J; Iversen BM
    Kidney Blood Press Res; 2001; 24(1):64-70. PubMed ID: 11174009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension. Comparison between nondiabetic individuals and patients with non-insulin-dependent diabetes mellitus.
    Maheux P; Facchini F; Jeppesen J; Greenfield MS; Clinkingbeard C; Chen YD; Reaven GM
    Am J Hypertens; 1994 May; 7(5):416-24. PubMed ID: 8060574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.
    Hobbs FR; Khan T; Collins B
    Br J Gen Pract; 2005 Jun; 55(515):437-43. PubMed ID: 15970067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
    Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients.
    Martínez Castelao A; Ibernón M; Sarrias X; Sanz V; Moreso F; Rama I; Grinyó JM
    Transplant Proc; 2003 Aug; 35(5):1736-8. PubMed ID: 12962776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys.
    Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ
    Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of doxazosin, a selective alpha 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension.
    Giorda C; Appendino M
    Metabolism; 1993 Nov; 42(11):1440-2. PubMed ID: 8231840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and availability of doxazosin in treating hypertensive patients with chronic renal failure.
    Mori Y; Matsubara H; Nose A; Shibasaki Y; Masaki H; Kosaki A; Okigaki M; Fujiyama S; Tanaka-Uchiyama Y; Hasegawa T; Iba O; Tateishi E; Amano K; Iwasaka T
    Hypertens Res; 2001 Jul; 24(4):359-63. PubMed ID: 11510747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
    Rabkin SW; Huff MW; Newman C; Sim D; Carruthers SG
    Hypertension; 1994 Aug; 24(2):241-8. PubMed ID: 8039850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertension.
    Black HR
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):866-9. PubMed ID: 12775963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
    Pool JL; Taylor AA; Nelson EB
    Am J Med; 1989 Aug; 87(2A):57S-61S. PubMed ID: 2569825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of nifedipine and doxazosin in essential hypertension.
    Donnelly R; Elliott HL; Meredith PA; Howie CA; Reid JL
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):479-86. PubMed ID: 1380588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.